Insider Trading Activity in: Proteostasis Therapeutics, Inc. $PTI

732fb432ac72880ffca54bb6302c9203

Proteostasis Therapeutics, Inc. (PTI) insiders have most recently took part in a trading activity. On Dec 18, 2017 Barrett M James, Director, 10% Owner bought 2,000,000 shares having total worth of $10,000,000 at the price of $5 per share, following the transaction a total of 5,554,610 shares owned by Barrett M James.

On the same day, New Enterprise Associates 12, Limited Partnership, 10% Owner bought 2,000,000 shares having total worth of $10,000,000 at the price of $5 per share, following the transaction a total of 5,554,610 shares owned by New Enterprise Associates 12, Limited Partnership.

The stock has experienced a total of 1 insider trades in the past three months. These trades include 1 sell activities .Furthermore, over the past 12 months , the stock was traded 8 times by insiders. In 8 of these trades, the insider was a seller .

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 0 1 107.91%
12 Month 0 8 -63.51%

Shares of Proteostasis Therapeutics, Inc. (PTI) traded down 10.42% on Dec 18, 2017, hitting $4.47. 1,495,354 shares of the company’s stock traded hands. Proteostasis Therapeutics, Inc. has a 52 week low of $1.56 and a 52 week high of $19.41. The company’s market cap is $0 million.

Proteostasis Therapeutics, Inc. (PTI) last announced its earnings results on Nov 14, 2017. The company reported -0.56 earnings per share (EPS) for the quarter, higher than the consensus estimate of -0.72 by $0.16. The company had revenue of $2 million for the quarter, compared to the consensus estimate of $1 million. During the same quarter in the previous year, the company posted -0.54 earnings per share. The company’s revenue for the quarter was down 10% on a year-over-year basis.

2017-11-14 2017-03-30 2016-11-10 2016-08-15
earnings per share -0.56 -0.38 -0.54 -0.47
Revenue(M) 1.55 0 1.72 1.45

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.